RMTI: Rockwell Medical, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 48.40
Enterprise Value ($M) 53.59
Book Value ($M) 21.29
Book Value / Share 0.73
Price / Book 2.27
NCAV ($M) -2.11
NCAV / Share -0.07
Price / NCAV -22.92

Profitability (mra)
Return on Invested Capital (ROIC) -0.21
Return on Assets (ROA) -0.18
Return on Equity (ROE) -0.60

Liquidity (mrq)
Quick Ratio 1.38
Current Ratio 1.73

Balance Sheet (mrq) ($M)
Current Assets 28.77
Assets 52.17
Liabilities 30.88
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 83.61
Operating Income -6.67
Net Income -8.44
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -9.41
Cash from Investing -3.04
Cash from Financing 11.34

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-14 13G/A Armistice Capital, Llc 9.99 178.07
09-06 13D/A Richmond Brothers, Inc. 0.00 -93.66

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-21 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-14 10-Q United States SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q
2023-08-14 10-Q United States SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q
2023-05-15 10-Q United States SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q
2023-03-30 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-03-27 59,214 250,790 23.61
2024-03-26 112,121 429,398 26.11
2024-03-25 84,801 305,132 27.79
2024-03-22 272,198 643,949 42.27

(click for more detail)

Similar Companies
REVB – Revelation Biosciences, Inc. RGC – Regencell Bioscience Holdings Limited
RGLS – Regulus Therapeutics Inc. RNAZ – TransCode Therapeutics, Inc.
RNXT – RenovoRx, Inc.


Financial data and stock pages provided by
Fintel.io